HSIC
Price
$67.54
Change
+$1.22 (+1.84%)
Updated
Aug 7, 10:39 AM (EDT)
Capitalization
9.7B
89 days until earnings call
SHTDY
Price
$11.96
Change
-$0.03 (-0.25%)
Updated
Aug 6 closing price
Capitalization
9.79B
Interact to see
Advertisement

HSIC vs SHTDY

Header iconHSIC vs SHTDY Comparison
Open Charts HSIC vs SHTDYBanner chart's image
Henry Schein
Price$67.54
Change+$1.22 (+1.84%)
Volume$100
Capitalization9.7B
Sinopharm Group
Price$11.96
Change-$0.03 (-0.25%)
Volume$8.06K
Capitalization9.79B
HSIC vs SHTDY Comparison Chart in %
Loading...
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HSIC vs. SHTDY commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Hold and SHTDY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (HSIC: $66.32 vs. SHTDY: $11.96)
Brand notoriety: HSIC and SHTDY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 176% vs. SHTDY: 74%
Market capitalization -- HSIC: $9.7B vs. SHTDY: $9.79B
HSIC [@Medical Distributors] is valued at $9.7B. SHTDY’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 0 FA rating(s) are green whileSHTDY’s FA Score has 2 green FA rating(s).

  • HSIC’s FA Score: 0 green, 5 red.
  • SHTDY’s FA Score: 2 green, 3 red.
According to our system of comparison, SHTDY is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 5 TA indicator(s) are bullish while SHTDY’s TA Score has 3 bullish TA indicator(s).

  • HSIC’s TA Score: 5 bullish, 6 bearish.
  • SHTDY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HSIC is a better buy in the short-term than SHTDY.

Price Growth

HSIC (@Medical Distributors) experienced а -4.69% price change this week, while SHTDY (@Medical Distributors) price change was -3.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.72%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +2.33%.

Reported Earning Dates

HSIC is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Distributors (-0.72% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHTDY($9.79B) and HSIC($9.71B) have the same market capitalization . HSIC has higher P/E ratio than SHTDY: HSIC (23.50) vs SHTDY (8.26). HSIC YTD gains are higher at: -4.169 vs. SHTDY (-8.311). SHTDY has higher annual earnings (EBITDA): 26.2B vs. HSIC (877M). SHTDY has higher revenues than HSIC: SHTDY (552B) vs HSIC (12.3B).
HSICSHTDYHSIC / SHTDY
Capitalization9.71B9.79B99%
EBITDA877M26.2B3%
Gain YTD-4.169-8.31150%
P/E Ratio23.508.26285%
Revenue12.3B552B2%
Total Cash171MN/A-
Total Debt2.74BN/A-
FUNDAMENTALS RATINGS
HSIC vs SHTDY: Fundamental Ratings
HSIC
SHTDY
OUTLOOK RATING
1..100
5812
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
7579
SMR RATING
1..100
63100
PRICE GROWTH RATING
1..100
6354
P/E GROWTH RATING
1..100
6927
SEASONALITY SCORE
1..100
5585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDY's Valuation (23) in the null industry is somewhat better than the same rating for HSIC (76) in the Medical Distributors industry. This means that SHTDY’s stock grew somewhat faster than HSIC’s over the last 12 months.

HSIC's Profit vs Risk Rating (75) in the Medical Distributors industry is in the same range as SHTDY (79) in the null industry. This means that HSIC’s stock grew similarly to SHTDY’s over the last 12 months.

HSIC's SMR Rating (63) in the Medical Distributors industry is somewhat better than the same rating for SHTDY (100) in the null industry. This means that HSIC’s stock grew somewhat faster than SHTDY’s over the last 12 months.

SHTDY's Price Growth Rating (54) in the null industry is in the same range as HSIC (63) in the Medical Distributors industry. This means that SHTDY’s stock grew similarly to HSIC’s over the last 12 months.

SHTDY's P/E Growth Rating (27) in the null industry is somewhat better than the same rating for HSIC (69) in the Medical Distributors industry. This means that SHTDY’s stock grew somewhat faster than HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICSHTDY
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
53%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 8 days ago
55%
Bearish Trend 7 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
HSIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABALX37.070.10
+0.27%
American Funds American Balanced A
RYVLX611.85N/A
N/A
Rydex NASDAQ-100® 2x Strategy A
FEIFX33.83N/A
N/A
Franklin Equity Income Adv
GMHPX12.65N/A
N/A
Goldman Sachs Rising Dividend Gr P
VVISX12.55N/A
N/A
Vulcan Value Partners Small Cap Instl

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
+2.29%
ZYXI - HSIC
27%
Poorly correlated
-0.64%
OMI - HSIC
22%
Poorly correlated
-1.23%
CAH - HSIC
20%
Poorly correlated
-1.04%
COR - HSIC
18%
Poorly correlated
-2.93%
SHTDY - HSIC
11%
Poorly correlated
-0.31%
More

SHTDY and

Correlation & Price change

A.I.dvisor tells us that SHTDY and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDY and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDY
1D Price
Change %
SHTDY100%
-0.31%
YI - SHTDY
21%
Poorly correlated
-1.60%
SHTDF - SHTDY
19%
Poorly correlated
N/A
HSIC - SHTDY
11%
Poorly correlated
+2.29%
ZYXI - SHTDY
9%
Poorly correlated
-0.64%
OMI - SHTDY
6%
Poorly correlated
-1.23%
More